Total medical devices industry M&A deals worth $23.26bn were announced globally in January 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 255.1% over the previous month of $6.55bn and a rise of 317.6% when compared with the last 12-month average, which stood at $5.57bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $21.21bn. At the country level, the US topped the list in terms of deal value at $21.21bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Middle East and Africa.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe top country in terms of M&A deals activity in January 2021 was the US with 25 deals, followed by the Germany with three and Israel with three.
In 2021, as of January, medical devices M&A deals worth $23.26bn were announced globally, marking an increase of 1206.4% year on year.
medical devices industry M&A deals in January 2021: Top deals
The top five M&A deals accounted for 87.5% of the overall value during January 2021.
The combined value of the top five medical devices M&A deals stood at $20.34bn, against the overall value of $23.26bn recorded for the month.
The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $880.85m asset transaction with Novasep Holding by Thermo Fisher Scientific
5) Koninklijke Philips’ acquisition of Capsule Technologies for $635m.
